About
Corbus Pharmaceuticals Holding (NASDAQ:CRBP) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701
Apr 14 2026
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
Apr 7 2026
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
Mar 18 2026
Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit
Mar 9 2026
Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update
Financials
Revenue
$0
Market Cap
$179.85 M
EPS
-5.90
Translate